S&P 500
5,970.37
+0.6%
+$34.43
DJI
42,519.64
+0.5%
+$214.16
NASDAQ
19,398.96
+0.8%
+$156.34
Bitcoin
105,350.00
-0.0%
-6.51
AAPL
$203.38
+0.8%
+$1.68
AMZN
$205.89
-0.4%
-$0.76
GOOG
$167.71
-1.6%
-$2.66
META
$667.31
-0.5%
-$3.59
MSFT
$463.24
+0.3%
+$1.28
NVDA
$141.38
+2.9%
+$4.00
TSLA
$344.95
+0.7%
+$2.26
Contineum Therapeutics (NASDAQ: CTNM)
$4.73
(6.8%)
$0.30
Price as of June 3, 2025, 3:56 p.m. ET
Contineum Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Contineum Therapeutics Company Info
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.